Skip to main content
. Author manuscript; available in PMC: 2022 Oct 25.
Published in final edited form as: Cancer Chemother Pharmacol. 2017 May 5;79(6):1221–1227. doi: 10.1007/s00280-017-3322-9

Table 1: Study Drug Schedules and Dose Levels and for Cilengitide and Paclitaxel.

Study drug dosing, route of administration, schedule, and retreatment interval.

Agent Dose Route Schedule Retreatment
Cilengitide As assigned by Randomization Center IV over 1 hour Levels −4, −3, −2, −1, 1*:
Days 1, 8 and 15
Every 21 days +/− 3 days
Level 2:
Days 1, 2, 8, 9, 15, 16
Paclitaxel As assigned by Randomization Center IV over 1 hour Days 1, 8 and 15 Every 21 days +/− 3 days
Dose Level Cilengitide (mg) Paclitaxel (mg/m2)
Dose Frequency
−4 1500 Once weekly 60
−3 2000 Once weekly 60
−2 2000 Once weekly 70
−1 2000 Once weekly 80
1* 2000 Once weekly 90
2 2000 Twice weekly 90
*

Starting Dose Level